Literature DB >> 31213485

Haematopoietic stem cell transplantation in CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

Fanny Mochel1,2, Cécile Delorme2,3, Virginie Czernecki3, Jerome Froger4, Florence Cormier2,3, Emmanuel Ellie5, Nathalie Fegueux6, Stéphane Lehéricy2,7, Serge Lumbroso8, Raphael Schiffmann9, Patrick Aubourg10,11, Emmanuel Roze2,3, Pierre Labauge12, Stephanie Nguyen13.   

Abstract

Entities:  

Keywords:  CSF1R; haematopoietic stem cell transplantation; leukoencephalopathy

Year:  2019        PMID: 31213485     DOI: 10.1136/jnnp-2019-320701

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  13 in total

1.  Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy.

Authors:  Woutje M Berdowski; Herma C van der Linde; Marjolein Breur; Nynke Oosterhof; Shanice Beerepoot; Leslie Sanderson; Lieve I Wijnands; Patrick de Jong; Elisa Tsai-Meu-Chong; Walter de Valk; Moniek de Witte; Wilfred F J van IJcken; Jeroen Demmers; Marjo S van der Knaap; Marianna Bugiani; Nicole I Wolf; Tjakko J van Ham
Journal:  Acta Neuropathol       Date:  2022-06-17       Impact factor: 15.887

2.  Altered intrinsic brain activity in patients with CSF1R-related leukoencephalopathy.

Authors:  Jingying Wu; Yikang Cao; Mengting Li; Binyin Li; Xize Jia; Li Cao
Journal:  Brain Imaging Behav       Date:  2022-04-07       Impact factor: 3.224

3.  Is Pre-Symptomatic Immunosuppression Protective in CSF1R-Related Leukoencephalopathy?

Authors:  Philip W Tipton; E Richard Stanley; Violeta Chitu; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2021-02-15       Impact factor: 10.338

Review 4.  Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy.

Authors:  Jinming Han; Heela Sarlus; Zbigniew K Wszolek; Virginija Danylaité Karrenbauer; Robert A Harris
Journal:  Acta Neuropathol Commun       Date:  2020-12-07       Impact factor: 7.801

5.  Attenuated CSF-1R signalling drives cerebrovascular pathology.

Authors:  Conor Delaney; Michael Farrell; Colin P Doherty; Kiva Brennan; Eoin O'Keeffe; Chris Greene; Kieva Byrne; Eoin Kelly; Niamh Birmingham; Paula Hickey; Simon Cronin; Savvas N Savvides; Sarah L Doyle; Matthew Campbell
Journal:  EMBO Mol Med       Date:  2020-12-22       Impact factor: 12.137

Review 6.  Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development.

Authors:  Spyros Papapetropoulos; Angela Pontius; Elizabeth Finger; Virginija Karrenbauer; David S Lynch; Matthew Brennan; Samantha Zappia; Wolfgang Koehler; Ludger Schoels; Stefanie N Hayer; Takuya Konno; Takeshi Ikeuchi; Troy Lund; Jennifer Orthmann-Murphy; Florian Eichler; Zbigniew K Wszolek
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

7.  Microglial reduction of colony stimulating factor-1 receptor expression is sufficient to confer adult onset leukodystrophy.

Authors:  Fabrizio Biundo; Violeta Chitu; Gabriel G L Shlager; Eun S Park; Maria E Gulinello; Kusumika Saha; Harmony C Ketchum; Christopher Fernandes; Şölen Gökhan; Mark F Mehler; E Richard Stanley
Journal:  Glia       Date:  2020-10-20       Impact factor: 7.452

Review 8.  Modeling CSF-1 receptor deficiency diseases - how close are we?

Authors:  Violeta Chitu; Şölen Gökhan; E Richard Stanley
Journal:  FEBS J       Date:  2021-07-05       Impact factor: 5.622

Review 9.  The multicellular interplay of microglia in health and disease: lessons from leukodystrophy.

Authors:  Woutje M Berdowski; Leslie E Sanderson; Tjakko J van Ham
Journal:  Dis Model Mech       Date:  2021-07-20       Impact factor: 5.758

Review 10.  Recent Advances in Basic Research for CSF1R-Microglial Encephalopathy.

Authors:  Yan-Li Wang; Fang-Ze Wang; Runzhi Li; Jiwei Jiang; Xiangrong Liu; Jun Xu
Journal:  Front Aging Neurosci       Date:  2021-12-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.